Nanoliposome is a Promising Carrier of Protein and Peptide Biomolecule for the Treatment of Cancer

  • Kumar Giri T
  • Giri A
  • Kumar Barman T
  • et al.
39Citations
Citations of this article
36Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Nano-liposomes are the newly developed delivery systems for cancer therapy that are finding a position particularly suitable as peptide and protein carriers. These are three-layered self-assembled structures with nanoparticulate carrier systems. The overall pharmacological properties of commonly used protein and peptide in cancer therapy can be improved by the incorporation of protein and peptide into the nano-liposome. The surface modifications can be made liposomes to make compatible with targeting ligands has made these nanocarriers for targeted delivery. This review discusses the method of preparation and characterization of liposome based protein peptide delivery for the treatment of cancer. This review also explores latest work intended for targeted treatment of cancer by nano-liposomal protein and peptide delivery system. This type of delivery is targeting protein and peptide to tumor site by avoiding the reticuloendothelial system. Methods of nano-liposome delivery containing protein and peptide are also highlighted.

Cite

CITATION STYLE

APA

Kumar Giri, T., Giri, A., Kumar Barman, T., & Maity, S. (2016). Nanoliposome is a Promising Carrier of Protein and Peptide Biomolecule for the Treatment of Cancer. Anti-Cancer Agents in Medicinal Chemistry, 16(7), 816–831. https://doi.org/10.2174/1871520616666151116121821

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free